Hutchison China Meditech Ltd (HCM)

 

Latest News

Total Voting Rights

RNS Number: 4771M Hutchison China Meditech Limited 30 April 2018 Total Voting Rights London: Monday, April 30, 2018: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at April 30, 2018, the issued share capital of Chi-Med consisted of 66,484,620 ordinary shares of US$1.00 each, wit...

Results of Annual General Meeting

RNS Number: 4310M Hutchison China Meditech Limited 27 April 2018 Results of Annual General Meeting London: Friday, April 27, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual General Meeting ("AGM") held on April 27, 2018 were duly passed. The ...

Grant of Share Options under Share Option Scheme

RNS Number: 8057L Hutchison China Meditech Limited 23 April 2018 Grant of Share Options under Share Option Scheme London: Monday, April 23, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) announces that on April 20, 2018 , it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual G...

Block Admission

RNS Number: 8055L Hutchison China Meditech Limited 23 April 2018 Block Admission London: Monday, April 23, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that an application has been made to the London Stock Exchange plc for a block admission of 1,425,597 ordinary shares, par value of US$1.00 each ("Ordinary...

All News

DateHeadlineSource
30-04-18Total Voting RightsRNS
27-04-18Results of Annual General MeetingRNS
23-04-18Grant of Share Options under Share Option SchemeRNS
23-04-18Block AdmissionRNS
29-03-18Total Voting RightsRNS
28-03-18Vesting of awards under Long Term Incentive PlanRNS
26-03-18Annual Report & Notice of Annual General MeetingRNS
21-03-18Director's Share DealingRNS
20-03-18Grant of Share Options under Share Option SchemeRNS
19-03-18Director's Share DealingRNS
12-03-18Publication of Form 20-FRNS
12-03-18Final Results and Key Clinical Programs UpdateRNS
06-03-18Phase Ib/II Trial of Epitinib in GlioblastomaRNS
13-02-18Hutchison China MediTech completes patient enrollment of Faluca StockMarketWire
13-02-18Enrolment completed Ph III FALUCA FruquintinibRNS
05-02-18Chi-Med to Announce 2017 Final ResultsRNS
29-12-17Block listing Interim ReviewRNS
29-12-17Total Voting RightsRNS
15-12-17Chi-Med initiates fruquintinib clinical trials in USStockMarketWire
15-12-17Chi-Med Initiates Fruquintinib US Clinical TrialsRNS
01-11-17Notification of Major HoldingsRNS
01-11-17NOTIFICATION OF MAJOR HOLDINGSRNS
31-10-17Chi-Med starts clinical trial of Inhibitor for gastric cancer patients StockMarketWire
31-10-17FRUTIGA, a Phase III trial of FruquintinibRNS
30-10-17Closing of U.S. Public Offering of ADSsRNS
27-10-17Chi-Med Announces Over-allotment OptionRNS
26-10-17Chi-Med prices US public offering StockMarketWire
26-10-17Chi-Med Announces Pricing Raising US$262 millionRNS
25-10-17Chi-Med plans $262m offering on Nasdaq StockMarketWire
25-10-17Chi-Med Announces Proposed Offering of ADSsRNS
19-10-17Notification of Major Interest in SharesRNS
17-10-17Chi-Med and AZ present encouraging data on lung cancer drug StockMarketWire
17-10-17Savolitinib Shows Encouraging Clinical ActivityRNS
16-10-17Chi-Med reports 'promising data' on lung cancer drugStockMarketWire
16-10-17Chi-Med Reports Preliminary Phase II dataRNS
12-10-17Appointment of DirectorRNS
29-09-17Best AIM companies of 2017 Interactive Investor
29-09-17Savolitinib and Fruquintinib presentations at WCLCRNS
29-09-17Oral Presentations at CSCO Annual MeetingRNS
29-09-17Total Voting RightsRNS

RSS feeds

  • Editorial news feed for LSE:HCM Editorial
  • Regulatory news feed for LSE:HCM Regulatory